Page last updated: 2024-12-08

4-nitrophenyl anthranilate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-nitrophenyl anthranilate: structure in second source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID193539
SCHEMBL ID4256409
MeSH IDM0066747

Synonyms (26)

Synonym
AKOS015838923
4-nitrophenyl 2-aminobenzoate
4-nitrophenylanthranilate
4-nitrophenyl anthranilate
19176-60-4
2-aminobenzoic acid 4-nitrophenyl ester
A0842
anthranilic acid 4-nitrophenyl ester
para-nitrophenyl anthranilate
A19735
4-bromo-m-anisidine;5-amino-2-bromoanisole
(4-nitrophenyl) 2-aminobenzoate
benzoic acid, 2-amino-, 4-nitrophenyl ester
FT-0637803
p-nitrophenyl anthranilate
SCHEMBL4256409
4-nitrophenyl 2-aminobenzoate #
IFHJJPYCVMFLMB-UHFFFAOYSA-N
DTXSID50172706
mfcd00056116
anthralinic acid 4-nitrophenyl ester
J-012395
4-nitrophenyl anthranilate (dea list i chemical)
FS-4393
D88338
CS-0435496
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (50.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.47 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]